Odonate Therapeutics Liabilities 2024

Odonate Therapeutics Aktienanalyse

What does Odonate Therapeutics do?

Odonate Therapeutics Inc is a biopharmaceutical company that specializes in the development of medications to assist patients with serious illnesses. The company was founded in 2013 by a team of experienced scientists, doctors, and experts from the pharmaceutical industry, with the goal of creating a revolutionary alternative to conventional cancer therapy. The idea was to develop a therapy that minimizes the unwanted effects of chemotherapy and radiation, while still being equally effective in fighting cancer. The business model of Odonate Therapeutics is based on the development of medications that specifically target certain substances in order to achieve maximum effectiveness and efficiency. The company primarily focuses on the research and development of cancer therapeutics and has already brought several innovative products to market, which are currently in the clinical testing phase. One of the main areas of Odonate Therapeutics' research and development is medication based on taxanes. Taxanes are a class of medications known for their effectiveness in fighting cancer. Odonate Therapeutics has the innovative idea of combining these substances with others to minimize the side effects of taxanes. The goal is to create a new generation of medications that offer a targeted approach to fighting cancer. Another focus of Odonate Therapeutics is the development of medications for the treatment of patients with breast cancer. The company has already conducted several testing phases for its flagship product, Odonate Therapeutics' Tesetaxel. Tesetaxel is a novel chemotherapy drug that aims to achieve higher efficacy with lower side effects. The results of the studies have been promising and have the potential to change the lives of patients with breast cancer. Another product developed by Odonate Therapeutics is the medication Odonate Therapeutics' Ladiratuzumab Vedotin. This is a cancer drug that was developed in phase 1 studies and is suitable for the treatment of patients with solid tumors. In this study, it has been shown to be well-tolerated and has shown promising results in fighting cancer cells. Over the past few years, Odonate Therapeutics Inc has achieved an impressive track record by developing innovative medications that have the potential to improve patients' lives. The research and development of cancer therapeutics is an area that requires increasing attention, as cancer remains one of the leading causes of death worldwide. Odonate Therapeutics aims to address this challenge by developing innovative products that meet the needs of patients. Overall, Odonate Therapeutics has quickly established a strong reputation in the biotech industry, and the company appears to be on a good path. The company has many promising medication pipeline programs, and the management team consists of experienced leaders focused on developing therapeutics and improving patients' quality of life. Odonate Therapeutics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing Odonate Therapeutics's Liabilities

Odonate Therapeutics's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Odonate Therapeutics's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Odonate Therapeutics's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Odonate Therapeutics's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Odonate Therapeutics’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Odonate Therapeutics stock

What is the level of liabilities of Odonate Therapeutics this year?

Odonate Therapeutics has a debt balance of 0 USD this year.

What were the liabilities of Odonate Therapeutics compared to the previous year?

The liabilities of Odonate Therapeutics have increased by 0% dropped compared to the previous year.

What are the consequences of high debt for investors of Odonate Therapeutics?

High liabilities can pose a risk for investors of Odonate Therapeutics, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in Odonate Therapeutics?

Low liabilities mean that Odonate Therapeutics has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of Odonate Therapeutics affect the company?

An increase in liabilities of Odonate Therapeutics can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of Odonate Therapeutics affect the company?

A decrease in the liabilities of Odonate Therapeutics can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of Odonate Therapeutics?

Some factors that can influence the liabilities of Odonate Therapeutics include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of Odonate Therapeutics so important for investors?

The liabilities of Odonate Therapeutics are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can Odonate Therapeutics take to modify the liabilities?

To change its liabilities, Odonate Therapeutics can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does Odonate Therapeutics pay?

Over the past 12 months, Odonate Therapeutics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Odonate Therapeutics is expected to pay a dividend of 0 USD.

What is the dividend yield of Odonate Therapeutics?

The current dividend yield of Odonate Therapeutics is .

When does Odonate Therapeutics pay dividends?

Odonate Therapeutics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Odonate Therapeutics?

Odonate Therapeutics paid dividends every year for the past 0 years.

What is the dividend of Odonate Therapeutics?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Odonate Therapeutics located?

Odonate Therapeutics is assigned to the 'Health' sector.

Wann musste ich die Aktien von Odonate Therapeutics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Odonate Therapeutics from 9/30/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/30/2024.

When did Odonate Therapeutics pay the last dividend?

The last dividend was paid out on 9/30/2024.

What was the dividend of Odonate Therapeutics in the year 2023?

In the year 2023, Odonate Therapeutics distributed 0 USD as dividends.

In which currency does Odonate Therapeutics pay out the dividend?

The dividends of Odonate Therapeutics are distributed in USD.